COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties-Reference-Cited by-同舟云学术

COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties

Published:2022-06 Issue:6 Volume:23 Page:693-695
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Kuderer Nicole M,Lyman Gary H

Publisher

Elsevier BV

Subject

Oncology

Reference10 articles.

1. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study;Kuderer;Lancet,2020

2. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study;Clift;BMJ,2020

3. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium;Grivas;Ann Oncol,2021

4. COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety;Fendler;Nat Rev Clin Oncol,2022

5. Association of COVID-19 vaccination with SARS-CoV-2 infection in patients with cancer: a US nationwide veterans affairs study;Wu;JAMA Oncol,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer;Journal of Clinical Oncology;2023-05-20

2. Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients;Cancer Medicine;2023-04-28

3. Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients;Frontiers in Immunology;2022-10-06

4. SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care;Best Practice & Research Clinical Haematology;2022-09

5. Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients;2022-07-15